Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health - PubMed (original) (raw)
Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health
Tatyana E Shaw et al. J Invest Dermatol. 2011 Jan.
Abstract
Using the 2003 National Survey of Children's Health sponsored by the federal Maternal and Child Health Bureau, we calculated prevalence estimates of eczema nationally and for each state among a nationally representative sample of 102,353 children 17 years of age and under. Our objective was to determine the national prevalence of eczema/atopic dermatitis in the US pediatric population and to further examine geographic and demographic associations previously reported in other countries. Overall, 10.7% of children were reported to have a diagnosis of eczema in the past 12 months. Prevalence ranged from 8.7 to 18.1% between states and districts, with the highest prevalence reported in many of the East Coast states, as well as in Nevada, Utah, and Idaho. After adjusting for confounders, metropolitan living was found to be a significant factor in predicting a higher disease prevalence with an odds ratio of 1.67 (95% confidence interval of 1.19-2.35, P=0.008). Black race (odds ratio 1.70, P=0.005) and education level in the household greater than high school (odds ratio 1.61, P=0.004) were also significantly associated with a higher prevalence of eczema. The wide range of prevalence suggests that social or environmental factors may influence disease expression.
Figures
Figure 1
Eczema prevalence in the United States shows a trend towards higher disease prevalence’s in the East Coast states.
Comment in
- Eczema across the world: the missing piece of the jigsaw revealed.
Williams HC. Williams HC. J Invest Dermatol. 2011 Jan;131(1):12-4. doi: 10.1038/jid.2010.333. J Invest Dermatol. 2011. PMID: 21157423
Similar articles
- Associations of childhood eczema severity: a US population-based study.
Silverberg JI, Simpson EL. Silverberg JI, et al. Dermatitis. 2014 May-Jun;25(3):107-14. doi: 10.1097/DER.0000000000000034. Dermatitis. 2014. PMID: 24819283 Free PMC article. - Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization.
Silverberg JI, Simpson EL. Silverberg JI, et al. Pediatr Allergy Immunol. 2013 Aug;24(5):476-86. doi: 10.1111/pai.12095. Epub 2013 Jun 16. Pediatr Allergy Immunol. 2013. PMID: 23773154 Free PMC article. - Prevalence and comorbidity of allergic eczema, rhinitis, and asthma in a city in western Turkey.
Yuksel H, Dinc G, Sakar A, Yilmaz O, Yorgancioglu A, Celik P, Ozcan C. Yuksel H, et al. J Investig Allergol Clin Immunol. 2008;18(1):31-5. J Investig Allergol Clin Immunol. 2008. PMID: 18361099 - Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children.
Hammer-Helmich L, Linneberg A, Thomsen SF, Glümer C. Hammer-Helmich L, et al. Scand J Public Health. 2014 Mar;42(2):120-7. doi: 10.1177/1403494813505727. Epub 2013 Oct 2. Scand J Public Health. 2014. PMID: 24089102 - Changing prevalence of allergic rhinitis and asthma.
Sly RM. Sly RM. Ann Allergy Asthma Immunol. 1999 Mar;82(3):233-48; quiz 248-52. doi: 10.1016/S1081-1206(10)62603-8. Ann Allergy Asthma Immunol. 1999. PMID: 10094214 Review.
Cited by
- Topical Probiotics Reduce Atopic Dermatitis Severity: A Systematic Review and Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
Flint E, Ahmad N, Rowland K, Hildebolt C, Raskin D. Flint E, et al. Cureus. 2024 Sep 23;16(9):e70001. doi: 10.7759/cureus.70001. eCollection 2024 Sep. Cureus. 2024. PMID: 39445279 Free PMC article. Review. - MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
Zeng YP, Nguyen GH, Jin HZ. Zeng YP, et al. Mol Cell Biochem. 2016 May;416(1-2):63-70. doi: 10.1007/s11010-016-2696-z. Epub 2016 Apr 5. Mol Cell Biochem. 2016. PMID: 27048505 - Volunteer bias in recruitment, retention, and blood sample donation in a randomised controlled trial involving mothers and their children at six months and two years: a longitudinal analysis.
Jordan S, Watkins A, Storey M, Allen SJ, Brooks CJ, Garaiova I, Heaven ML, Jones R, Plummer SF, Russell IT, Thornton CA, Morgan G. Jordan S, et al. PLoS One. 2013 Jul 9;8(7):e67912. doi: 10.1371/journal.pone.0067912. Print 2013. PLoS One. 2013. PMID: 23874465 Free PMC article. - Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis.
Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD; NISC Comparative Sequence Program; Murray PR, Turner ML, Segre JA. Kong HH, et al. Genome Res. 2012 May;22(5):850-9. doi: 10.1101/gr.131029.111. Epub 2012 Feb 6. Genome Res. 2012. PMID: 22310478 Free PMC article. - The burden of atopic dermatitis in Portuguese patients: an observational study.
Coelho PS, Apalhão M, Victorino G, Cardoso C, Camilo J, Silva JM. Coelho PS, et al. Sci Rep. 2024 Mar 2;14(1):5181. doi: 10.1038/s41598-024-55965-y. Sci Rep. 2024. PMID: 38431751 Free PMC article.
References
- Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phase one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–43. - PubMed
- Blumberg SJ, Olson L, Frankel M, Osborn L, Srinath KP, Giambo P. Design and operation of the National Survey of Children’s Health (NSCH) Vital Health Stat. 2005;143:1–124. [National Survey of Children’s Health (NSCH), 2003 www.childhealthdata.org] - PubMed
- Carroll CL, Balkrisyhnan R, Feldman SR, et al. The burden of atopic dermatitis: impact on the patient, family and society. Pediatr Dermatol. 2005;22:192–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous